Genetic Signatures Limited (ASX:GSS)
Australia · Delayed Price · Currency is AUD 0.0580
-0.0030 (-4.92%)
Aug 11, 2026, 3:53 PM AEST
Genetic Signatures Market Cap
Genetic Signatures has a market cap or net worth of 13.17 million as of August 11, 2026. Its market cap has decreased by -81.29% in one year.
Market Cap
13.17M
Enterprise Value
-16.14M
Revenue
19.94M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.06
ChartMarket Cap Chart
Since March 31, 2015, Genetic Signatures's market cap has decreased from 35.38M to 13.17M, a decrease of -62.76%. That is a compound annual growth rate of -8.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 13.17M | -76.80% |
| Dec 31, 2025 | 56.79M | -60.32% |
| Dec 31, 2024 | 143.10M | 99.47% |
| Dec 29, 2023 | 71.74M | -43.15% |
| Dec 30, 2022 | 126.20M | -50.73% |
| Dec 31, 2021 | 256.15M | -10.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Australian Clinical Labs | 441.54M |
| Healius | 304.99M |
| Monash IVF Group | 266.90M |
| Cryosite | 58.57M |
| Microba Life Sciences | 34.42M |
| Rhythm Biosciences | 34.33M |
| INOVIQ | 28.86M |
| BCAL Diagnostics | 23.96M |